Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3483066017 | Product containing entacapone (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3714641012 | Entacapone-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Entacapone-containing product | Is a | Catechol-O-methyltransferase inhibitor-containing product | true | Inferred relationship | Some | ||
| Entacapone-containing product | Is a | Nitrogen and/or nitrogen compound-containing product | true | Inferred relationship | Some | ||
| Entacapone-containing product | Is a | Phenol structure-containing product | true | Inferred relationship | Some | ||
| Entacapone-containing product | Plays role | Antiparkinson therapeutic role | true | Inferred relationship | Some | ||
| Entacapone-containing product | Is a | Antiparkinson agent | true | Inferred relationship | Some | ||
| Entacapone-containing product | Has active ingredient | Entacapone | true | Inferred relationship | Some | 1 | |
| Entacapone-containing product | Is a | Medicinal product categorised by structure | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Entacapone only product | Is a | True | Entacapone-containing product | Inferred relationship | Some | |
| Entacapone 200 mg oral tablet | Is a | False | Entacapone-containing product | Inferred relationship | Some | |
| Carbidopa- and entacapone- and levodopa-containing product | Is a | True | Entacapone-containing product | Inferred relationship | Some | |
| Entacapone-containing product in oral dose form | Is a | True | Entacapone-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR